HomeAI · summaries
Storia in 3 fonti
Compounders maintain a firm grip on the GLP-1 market
Despite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients taking are still taking cheaper weight-loss alternatives.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
washingtonexaminer.com
The deceptive advertisements masking drug dangers
Compounded GLP-1 weight-loss ads are flooding social media without FDA oversight or safety warnings — putting patients, especially teenagers, at serious risk.
- ·
biopharmadive.com
Compounders maintain a firm grip on the GLP-1 market
Despite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients taking are still taking cheaper weight-loss alternatives.
- ·
morningstar.com
Study Finds Some Medical Spas Still Selling Compounded Weight-Loss Drugs From Pharmacies With Regulatory Concerns
Study Finds Some Medical Spas Still Selling Compounded Weight-Loss Drugs From Pharmacies With Regulatory Concerns